89bio • ETNB
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Rohan Palekar$865.6M
Market Cap • 19/04/20242019
(há 5 anos)
2019
(5 years ago)
NASDAQ
Listagem
San Francisco
Sede • California45
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ETNBSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.